메뉴 건너뛰기




Volumn 25, Issue 3, 2015, Pages 185-190

Active surveillance for prostate cancer: Can we modernize contemporary protocols to improve patient selection and outcomes in the focal therapy era?

Author keywords

active surveillance; fusion biopsy; molecular markers; MRI; prostate cancer

Indexed keywords

TUMOR MARKER; PROSTATE SPECIFIC ANTIGEN;

EID: 84928530975     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0000000000000168     Document Type: Review
Times cited : (20)

References (53)
  • 2
    • 78049485263 scopus 로고    scopus 로고
    • Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
    • Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-2917.
    • (2010) Int J Cancer , vol.127 , pp. 2893-2917
    • Ferlay, J.1    Shin, H.R.2    Bray, F.3
  • 3
    • 84898543637 scopus 로고    scopus 로고
    • Overdetection in screening for prostate cancer
    • Hugosson J, Carlsson S. Overdetection in screening for prostate cancer. Curr Opin Urol 2014; 24:256-263.
    • (2014) Curr Opin Urol , vol.24 , pp. 256-263
    • Hugosson, J.1    Carlsson, S.2
  • 5
    • 84919871373 scopus 로고    scopus 로고
    • Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
    • Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014; 384:2027-2035.
    • (2014) Lancet , vol.384 , pp. 2027-2035
    • Schroder, F.H.1    Hugosson, J.2    Roobol, M.J.3
  • 6
    • 84864008031 scopus 로고    scopus 로고
    • Radical prostatectomy versus observation for localized prostate cancer
    • Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367:203-213.
    • (2012) N Engl J Med , vol.367 , pp. 203-213
    • Wilt, T.J.1    Brawer, M.K.2    Jones, K.M.3
  • 7
    • 4644233846 scopus 로고    scopus 로고
    • Localized prostate cancer: Quality of life meets Whitmore's legacy
    • Bermejo C, Kristal AR, Zeliadt SB, et al. Localized prostate cancer: quality of life meets Whitmore's legacy. J Natl Cancer Inst 2004; 96:1348-1349.
    • (2004) J Natl Cancer Inst , vol.96 , pp. 1348-1349
    • Bermejo, C.1    Kristal, A.R.2    Zeliadt, S.B.3
  • 8
    • 84898543801 scopus 로고    scopus 로고
    • The role of focal therapy in the management of localised prostate cancer: A systematic review
    • Valerio M, Ahmed HU, Emberton M, et al. The role of focal therapy in the management of localised prostate cancer: A systematic review. Eur Urol 2014; 66:732-751.
    • (2014) Eur Urol , vol.66 , pp. 732-751
    • Valerio, M.1    Ahmed, H.U.2    Emberton, M.3
  • 9
    • 84914170524 scopus 로고    scopus 로고
    • Low-Risk and Very-Low-Risk Prostate Cancer: Is there a Role for Focal Therapy in the Era of Active Surveillance? Yes the the two approaches complement each other
    • Klotz L, Polascik TJ. Low-Risk and Very-Low-Risk Prostate Cancer: Is there a Role for Focal Therapy in the Era of Active Surveillance? Yes the the two approaches complement each other. Oncology 2014; 28:950.
    • (2014) Oncology , vol.28 , pp. 950
    • Klotz, L.1    Polascik, T.J.2
  • 10
    • 73949130115 scopus 로고    scopus 로고
    • Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    • Klotz L, Zhang L, Lam A, et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010; 28:126-131.
    • (2010) J Clin Oncol , vol.28 , pp. 126-131
    • Klotz, L.1    Zhang, L.2    Lam, A.3
  • 11
    • 84868563896 scopus 로고    scopus 로고
    • Active surveillance for prostate cancer: A systematic review of the literature
    • Dall'Era MA, Albertsen PC, Bangma C, et al. Active surveillance for prostate cancer: A systematic review of the literature. Eur Urol 2012; 62:976-983.
    • (2012) Eur Urol , vol.62 , pp. 976-983
    • Dall'era, M.A.1    Albertsen, P.C.2    Bangma, C.3
  • 12
    • 79957957477 scopus 로고    scopus 로고
    • Active surveillance program for prostate cancer: An update of the Johns Hopkins experience
    • Tosoian JJ, Trock BJ, Landis P, et al. Active surveillance program for prostate cancer: An update of the Johns Hopkins experience. J Clin Oncol 2011; 29:2185-2190.
    • (2011) J Clin Oncol , vol.29 , pp. 2185-2190
    • Tosoian, J.J.1    Trock, B.J.2    Landis, P.3
  • 13
    • 79960240491 scopus 로고    scopus 로고
    • Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance
    • Porten SP, Whitson JM, Cowan JE, et al. Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. J Clin Oncol 2011; 29:2795-2800.
    • (2011) J Clin Oncol , vol.29 , pp. 2795-2800
    • Porten, S.P.1    Whitson, J.M.2    Cowan, J.E.3
  • 14
    • 53249155905 scopus 로고    scopus 로고
    • Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance
    • Berglund RK, Masterson TA, Vora KC, et al. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance. J Urol 2008; 180:1964-1967.
    • (2008) J Urol , vol.180 , pp. 1964-1967
    • Berglund, R.K.1    Masterson, T.A.2    Vora, K.C.3
  • 15
    • 83955162939 scopus 로고    scopus 로고
    • Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program
    • Bul M, van den Bergh RCN, Rannikko A, et al. Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program. Eur Urol 2012; 61:370-377.
    • (2012) Eur Urol , vol.61 , pp. 370-377
    • Bul, M.1    Van Den Bergh, R.C.N.2    Rannikko, A.3
  • 16
    • 34547670085 scopus 로고    scopus 로고
    • Predictors of histological disease progression in untreated, localized prostate cancer
    • Venkitaraman R, Norman A, Woode-Amissah R, et al. Predictors of histological disease progression in untreated, localized prostate cancer. J Urol 2007; 178:833-837.
    • (2007) J Urol , vol.178 , pp. 833-837
    • Venkitaraman, R.1    Norman, A.2    Woode-Amissah, R.3
  • 17
    • 78049478880 scopus 로고    scopus 로고
    • Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment
    • Soloway MS, Soloway CT, Eldefrawy A, et al. Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment. Eur Urol 2010; 58:831-835.
    • (2010) Eur Urol , vol.58 , pp. 831-835
    • Soloway, M.S.1    Soloway, C.T.2    Eldefrawy, A.3
  • 18
    • 84880306415 scopus 로고    scopus 로고
    • Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer
    • (Northwood, London, England)
    • Fu Q, Moul JW, Banez LL, et al. Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer. Med Oncol (Northwood, London, England) 2012; 29:3339-3344.
    • (2012) Med Oncol , vol.29 , pp. 3339-3344
    • Fu, Q.1    Moul, J.W.2    Banez, L.L.3
  • 19
    • 77952876424 scopus 로고    scopus 로고
    • The Epstein criteria predict for organconfined but not insignificant disease and a high likelihood of cure at radical prostatectomy
    • Lee MC, Dong F, Stephenson AJ, et al. The Epstein criteria predict for organconfined but not insignificant disease and a high likelihood of cure at radical prostatectomy. Eur Urol 2010; 58:90-95.
    • (2010) Eur Urol , vol.58 , pp. 90-95
    • Lee, M.C.1    Dong, F.2    Stephenson, A.J.3
  • 20
    • 84872963407 scopus 로고    scopus 로고
    • Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database
    • Abern MR, Aronson WJ, Terris MK, et al. Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH database. The Prostate 2013; 73:409-417.
    • (2013) The Prostate , vol.73 , pp. 409-417
    • Abern, M.R.1    Aronson, W.J.2    Terris, M.K.3
  • 21
    • 84911987418 scopus 로고    scopus 로고
    • Characteristics and experiences of patients with localized prostate cancer who left an active surveillance program
    • Berger ZD, Yeh JC, Carter HB, Pollack CE. Characteristics and experiences of patients with localized prostate cancer who left an active surveillance program. The Patient 2014; 7:427-436.
    • (2014) The Patient , vol.7 , pp. 427-436
    • Berger, Z.D.1    Yeh, J.C.2    Carter, H.B.3    Pollack, C.E.4
  • 22
    • 84929302920 scopus 로고    scopus 로고
    • A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels
    • [Epub ahead of print]
    • Venderbos LDF., van den Bergh RCN., Roobol MJ, et al. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels. Psycho-Oncology 2014. [Epub ahead of print]. doi: 10.1002/pon. 3657.
    • (2014) Psycho-Oncology
    • Venderbos, L.D.F.1    Van Den Bergh, R.C.N.2    Roobol, M.J.3
  • 23
    • 69249119890 scopus 로고    scopus 로고
    • Anxiety and distress during active surveillance for early prostate cancer
    • van den Bergh RC, Essink-Bot ML, Roobol MJ, et al. Anxiety and distress during active surveillance for early prostate cancer. Cancer 2009; 115:3868-3878.
    • (2009) Cancer , vol.115 , pp. 3868-3878
    • Van Den Bergh, R.C.1    Essink-Bot, M.L.2    Roobol, M.J.3
  • 24
    • 41149115801 scopus 로고    scopus 로고
    • Staging saturation biopsy in patients with prostate cancer on active surveillance protocol
    • Abouassaly R, Lane BR, Jones JS. Staging saturation biopsy in patients with prostate cancer on active surveillance protocol. Urology 2008; 71:573-577.
    • (2008) Urology , vol.71 , pp. 573-577
    • Abouassaly, R.1    Lane, B.R.2    Jones, J.S.3
  • 25
    • 70350443250 scopus 로고    scopus 로고
    • Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails
    • Duffield AS, Lee TK, Miyamoto H, et al. Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails. J Urol 2009; 182:2274-2278.
    • (2009) J Urol , vol.182 , pp. 2274-2278
    • Duffield, A.S.1    Lee, T.K.2    Miyamoto, H.3
  • 26
    • 84879556419 scopus 로고    scopus 로고
    • Short-term functional outcomes and complications associated with transperineal template prostate mapping biopsy
    • Tsivian M, Abern MR, Qi P, Polascik TJ. Short-term functional outcomes and complications associated with transperineal template prostate mapping biopsy. Urology 2013; 82:166-170.
    • (2013) Urology , vol.82 , pp. 166-170
    • Tsivian, M.1    Abern, M.R.2    Qi, P.3    Polascik, T.J.4
  • 27
    • 84876294696 scopus 로고    scopus 로고
    • Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens
    • Crawford ED, Rove KO, Barqawi AB, et al. Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens. The Prostate 2013; 73:778-787.
    • (2013) The Prostate , vol.73 , pp. 778-787
    • Crawford, E.D.1    Rove, K.O.2    Barqawi, A.B.3
  • 28
    • 43949119459 scopus 로고    scopus 로고
    • The morbidity of transperineal template-guided prostate mapping biopsy
    • Merrick GS, Taubenslag W, Andreini H, et al. The morbidity of transperineal template-guided prostate mapping biopsy. BJU Int 2008; 101:1524-1529.
    • (2008) BJU Int , vol.101 , pp. 1524-1529
    • Merrick, G.S.1    Taubenslag, W.2    Andreini, H.3
  • 29
    • 84883184816 scopus 로고    scopus 로고
    • Multiparametric MR imaging for detection of clinically significant prostate cancer: A validation cohort study with transperineal template prostate mapping as the reference standard
    • Arumainayagam N, Ahmed HU, Moore CM, et al. Multiparametric MR imaging for detection of clinically significant prostate cancer: A validation cohort study with transperineal template prostate mapping as the reference standard. Radiology 2013; 268:761-769.
    • (2013) Radiology , vol.268 , pp. 761-769
    • Arumainayagam, N.1    Ahmed, H.U.2    Moore, C.M.3
  • 30
    • 84861096940 scopus 로고    scopus 로고
    • Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected
    • Rosenkrantz AB, Mendrinos S, Babb JS, Taneja SS. Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected. J Urol 2012; 187:2032-2038.
    • (2012) J Urol , vol.187 , pp. 2032-2038
    • Rosenkrantz, A.B.1    Mendrinos, S.2    Babb, J.S.3    Taneja, S.S.4
  • 32
    • 84925947273 scopus 로고    scopus 로고
    • Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy
    • Gupta RT, Faridi KF, Singh AA, et al. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy. Urol Oncol 2014; 32:1292-1299.
    • (2014) Urol Oncol , vol.32 , pp. 1292-1299
    • Gupta, R.T.1    Faridi, K.F.2    Singh, A.A.3
  • 33
    • 84871242251 scopus 로고    scopus 로고
    • MRI-ultrasound fusion for guidance of targeted prostate biopsy
    • Marks L, Young S, Natarajan S. MRI-ultrasound fusion for guidance of targeted prostate biopsy. Curr Opin Urol 2013; 23:43-50.
    • (2013) Curr Opin Urol , vol.23 , pp. 43-50
    • Marks, L.1    Young, S.2    Natarajan, S.3
  • 34
    • 84898539555 scopus 로고    scopus 로고
    • A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: The PROFUS trial
    • Wysock JS, Rosenkrantz AB, Huang WC, et al. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Eur Urol 2014; 66:343-351.
    • (2014) Eur Urol , vol.66 , pp. 343-351
    • Wysock, J.S.1    Rosenkrantz, A.B.2    Huang, W.C.3
  • 35
    • 84870489591 scopus 로고    scopus 로고
    • Image-guided prostate biopsy using magnetic resonance imaging-derived targets: A systematic review
    • Moore CM, Robertson NL, Arsanious N, et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: A systematic review. Eur Urol 2013; 63:125-140.
    • (2013) Eur Urol , vol.63 , pp. 125-140
    • Moore, C.M.1    Robertson, N.L.2    Arsanious, N.3
  • 36
    • 84904987996 scopus 로고    scopus 로고
    • The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer
    • Marliere F, Puech P, Benkirane A, et al. The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer. World J Urol 2014; 32:951-958.
    • (2014) World J Urol , vol.32 , pp. 951-958
    • Marliere, F.1    Puech, P.2    Benkirane, A.3
  • 37
    • 84928543098 scopus 로고    scopus 로고
    • V6-06 use of MRI/US fusion for targeted prostate biopsy in active surveillance
    • Le J, Filson C, Margolis D, Marks L. V6-06 Use of MRI/US Fusion for Targeted Prostate Biopsy in Active Surveillance. The Journal of Urology. 2014;191(4S):e679.
    • (2014) The Journal of Urology , vol.191 , Issue.4 S , pp. e679
    • Le, J.1    Filson, C.2    Margolis, D.3    Marks, L.4
  • 38
    • 84919778618 scopus 로고    scopus 로고
    • Transperineal in-bore 3-T MR imaging-guided prostate biopsy: A prospective clinical observational study
    • Penzkofer T, Tuncali K, Fedorov A, et al. Transperineal in-bore 3-T MR imaging-guided prostate biopsy: A prospective clinical observational study. Radiology 2015; 274:170-180.
    • (2015) Radiology , vol.274 , pp. 170-180
    • Penzkofer, T.1    Tuncali, K.2    Fedorov, A.3
  • 39
    • 84902079840 scopus 로고    scopus 로고
    • Targeted prostate biopsies: The complexity behind a simple concept
    • Passoni NM, Polascik TJ. Targeted prostate biopsies: the complexity behind a simple concept. Eur Urol 2014; 66:30-31.
    • (2014) Eur Urol , vol.66 , pp. 30-31
    • Passoni, N.M.1    Polascik, T.J.2
  • 40
    • 84928549786 scopus 로고    scopus 로고
    • A guide for clinicians in the evaluation of emerging molecular diagnostics for newly diagnosed prostate cancer
    • Canfield SE, Kibel AS, Kemeter MJ, et al. A guide for clinicians in the evaluation of emerging molecular diagnostics for newly diagnosed prostate cancer. Rev Urol 2014; 16:172-180.
    • (2014) Rev Urol , vol.16 , pp. 172-180
    • Canfield, S.E.1    Kibel, A.S.2    Kemeter, M.J.3
  • 41
    • 46449132555 scopus 로고    scopus 로고
    • [-2]proenzyme prostate specific antigen for prostate cancer detection: A national cancer institute early detection research network validation study
    • Sokoll LJ, Wang Y, Feng Z, et al. [-2]proenzyme prostate specific antigen for prostate cancer detection: A national cancer institute early detection research network validation study. J Urol 2008; 180:539-543.
    • (2008) J Urol , vol.180 , pp. 539-543
    • Sokoll, L.J.1    Wang, Y.2    Feng, Z.3
  • 42
    • 79952336412 scopus 로고    scopus 로고
    • ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program
    • Isharwal S, Makarov DV, Sokoll LJ, et al. ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program. Urology 2011; 77:763e1-7636e.
    • (2011) Urology , vol.77 , pp. 763e1-7636e
    • Isharwal, S.1    Makarov, D.V.2    Sokoll, L.J.3
  • 43
    • 0033429470 scopus 로고    scopus 로고
    • DD3: A new prostate-specific gene, highly overexpressed in prostate cancer
    • Bussemakers MJG, Van Bokhoven A, Verhaegh GW, et al. DD3: A new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 1999; 59:5975-5979.
    • (1999) Cancer Res , vol.59 , pp. 5975-5979
    • Bussemakers, M.J.G.1    Van Bokhoven, A.2    Verhaegh, G.W.3
  • 44
    • 80053315206 scopus 로고    scopus 로고
    • Contemporary role of prostate cancer antigen 3 in the management of prostate cancer
    • Auprich M, Bjartell A, Chun FKH, et al. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer. Eur Urol 2011; 60:1045-1054.
    • (2011) Eur Urol , vol.60 , pp. 1045-1054
    • Auprich, M.1    Bjartell, A.2    Chun, F.K.H.3
  • 45
    • 73749086977 scopus 로고    scopus 로고
    • Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program
    • Tosoian JJ, Loeb S, Kettermann A, et al. Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program. J Urol 2010; 183:534-538.
    • (2010) J Urol , vol.183 , pp. 534-538
    • Tosoian, J.J.1    Loeb, S.2    Kettermann, A.3
  • 46
    • 78650250585 scopus 로고    scopus 로고
    • Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging
    • Auprich M, Chun FKH, Ward JF, et al. Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging. Eur Urol 2011; 59:96-105.
    • (2011) Eur Urol , vol.59 , pp. 96-105
    • Auprich, M.1    Chun, F.K.H.2    Ward, J.F.3
  • 47
    • 84898538811 scopus 로고    scopus 로고
    • Circulating biomarkers for discriminating indolent from aggressive disease in prostate cancer active surveillance
    • Trock BJ. Circulating biomarkers for discriminating indolent from aggressive disease in prostate cancer active surveillance. CurrOpin Urol 2014; 24:293-302.
    • (2014) CurrOpin Urol , vol.24 , pp. 293-302
    • Trock, B.J.1
  • 48
    • 84907578628 scopus 로고    scopus 로고
    • ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer
    • Berg KD, Vainer B, Thomsen FB, et al. ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer. Eur Urol 2014.
    • Eur Urol 2014
    • Berg, K.D.1    Vainer, B.2    Thomsen, F.B.3
  • 50
    • 84905922873 scopus 로고    scopus 로고
    • A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling
    • Klein EA, Cooperberg MR, Magi-Galluzzi C, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur Urol 2014; 66:550-560.
    • (2014) Eur Urol , vol.66 , pp. 550-560
    • Klein, E.A.1    Cooperberg, M.R.2    Magi-Galluzzi, C.3
  • 51
    • 84862777506 scopus 로고    scopus 로고
    • Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
    • Cuzick J, Berney DM, Fisher G, et al. Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer 2012; 106:1095-1099.
    • (2012) Br J Cancer , vol.106 , pp. 1095-1099
    • Cuzick, J.1    Berney, D.M.2    Fisher, G.3
  • 52
    • 79952042778 scopus 로고    scopus 로고
    • Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: A retrospective study
    • Cuzick J, Swanson GP, Fisher G, et al. Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: A retrospective study. Lancet Oncol 2011; 12:245-255.
    • (2011) Lancet Oncol , vol.12 , pp. 245-255
    • Cuzick, J.1    Swanson, G.P.2    Fisher, G.3
  • 53
    • 84876080452 scopus 로고    scopus 로고
    • Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort
    • Cooperberg MR, Simko JP, Cowan JE, et al. Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort. J Clin Oncol 2013; 31:1428-1434.
    • (2013) J Clin Oncol , vol.31 , pp. 1428-1434
    • Cooperberg, M.R.1    Simko, J.P.2    Cowan, J.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.